Cargando…
Tau Aggregation Inhibiting Peptides as Potential Therapeutics for Alzheimer Disease
Alzheimer disease (AD) is the most common progressive neurodegenerative disorder. AD causes enormous personal and economic burden to society as currently only limited palliative therapeutic options are available. The pathological hallmarks of the disease are extracellular plaques, composed of fibril...
Autores principales: | Aillaud, Isabelle, Funke, Susanne Aileen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10006036/ https://www.ncbi.nlm.nih.gov/pubmed/35596819 http://dx.doi.org/10.1007/s10571-022-01230-7 |
Ejemplares similares
-
A novel D-amino acid peptide with therapeutic potential (ISAD1) inhibits aggregation of neurotoxic disease-relevant mutant Tau and prevents Tau toxicity in vitro
por: Aillaud, Isabelle, et al.
Publicado: (2022) -
Potent Tau Aggregation Inhibitor D‐Peptides Selected against Tau‐Repeat 2 Using Mirror Image Phage Display
por: Malhis, Marwa, et al.
Publicado: (2021) -
Peptides for Therapy and Diagnosis of Alzheimer’s Disease
por: Funke, Susanne Aileen, et al.
Publicado: (2012) -
Selection and Characterization of Tau Binding ᴅ-Enantiomeric Peptides with Potential for Therapy of Alzheimer Disease
por: Dammers, Christina, et al.
Publicado: (2016) -
The toxicity of tau in Alzheimer disease: turnover, targets and potential therapeutics
por: Pritchard, Susanne M, et al.
Publicado: (2011)